Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|March 17, 2018
Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells Are Induced by Human Mycobacterium tuberculosis InfectionCheleka A M Mpande, One B Dintwe, Munyaradzi Musvosvi, et al.Ebiomedicine|February 20, 2021
Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infectionCheleka A M Mpande, Virginie Rozot, Boitumelo Mosito, et al.European Journal of Immunology|June 6, 2013
Heterologous vaccination against human tuberculosis modulates antigen-specific CD4+ T-cell functionOne B Dintwe, Cheryl L Day, Erica Smit, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 4, 2013
Varicella zoster-specific CD4+Foxp3+ T cells accumulate after cutaneous antigen challenge in humansMilica Vukmanovic-Stejic, Daisy Sandhu, Toni O Sobande, et al.Vaccine|April 12, 2015
A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringeHennie D Geldenhuys, Helen Mearns, Jennifer Foster, et al.Nature Communications|June 18, 2024
Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosisOne B Dintwe, Lamar Ballweber Fleming, Valentin Voillet, et al.Viruses|September 28, 2024
Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune ResponsesYing Huang, Shomoita Alam, Erica Andersen-Nissen, et al.Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.Journal of Leukocyte Biology|July 22, 2022
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine-induced T-cell responsesOne B Dintwe, Stephen C De Rosa, Yunda Huang, et al.Plos Medicine|March 19, 2024
Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trialZoe Moodie, Erica Andersen-Nissen, Nicole Grunenberg, et al.Pageof 1